A venture arm of a healthcare distribution and information technology solutions company is a stage-agnostic investor, and makes investments from Series A to growth stage. Investments are therefore varied in size relative to the type of investment; initial allocations are most often from $3-7 million with the possibility of follow-on investments up to $15 million. The firm is open to opportunities worldwide but has previously focused on investing in the USA, Canada and Europe.
The firm focuses on four key areas of innovation in healthcare; alternative care delivery models, consumer health, pharma value chain, and data value chain. The firm invests in technologies at all stages.
The firm has no set requirements for IRR or other metrics, but instead focuses on how a company’s technology fits with the four focus areas of the firm’s investment space, and how the firm can potentially add value to the company.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply